Castelion
Builds low-cost, mass-producible hypersonic strike missiles for defense
$1BSeries C
Role not disclosedActivity from announced rounds
Builds low-cost, mass-producible hypersonic strike missiles for defense
Manufactures large, high-power satellites.
AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.
Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives
Provides real-time analytics, data warehousing, observability, and AI/ML infrastructure
Develops medicines targeting historically undruggable protein targets in cancer